Established in 2022 and based in Boulder, Colorado, Buff Gold Ventures is a venture capital firm focused on investing in deep tech companies affiliated with the University of Colorado.
Polaris Electro-Optics specializes in the manufacture of ferroelectric nematic liquid crystals for electro-optic modulators. Utilizing patented material and design innovations, the company offers high-speed, energy-efficient integrated photonics products, serving the communications and computation industries.
Tynt Technologies
Venture Round in 2023
Founded in 2020, Tynt Technologies specializes in developing smart windows that minimize glare while preserving views. These windows enhance occupant comfort and significantly reduce energy consumption from lighting and HVAC systems.
LongPath Technologies
Series A in 2022
LongPath Technologies develops laser-based monitoring solutions for the oil and gas sector. The company offers long-range laser systems and managed infrastructure for continuous emissions monitoring across large areas, capable of detecting leaks and identifying the absorption fingerprints of multiple molecules. This enables emission source identification and rate quantification in a cost-effective manner, helping operators validate gas performance and support safer, more sustainable operations.
Vitro3D
Seed Round in 2022
Vitro3D specializes in advanced volumetric 3D printing solutions. It combines innovative hardware, software, and material formulations to enable high-resolution production of parts with a broader range of material properties, requiring minimal post-processing.
Think Bioscience
Seed Round in 2022
Think Bioscience is a company focused on advancing synthetic biology to enhance the development of medicines. It employs innovative technology to encode complex molecular objectives within microbial hosts, facilitating the identification, construction, and evolution of small molecules. By leveraging living systems, Think Bioscience aims to transform the drug discovery process, providing medical researchers with powerful tools to create better therapeutic solutions. The company's approach represents a significant evolution in the field of synthetic biology, positioning it as a leader in the quest for improved medicinal outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.